TKPHF - Takeda Pharmaceutical GAAP EPS of ¥94.00 revenue of ¥3212.9B; reaffirms FY23 guidance
2024-02-01 01:21:16 ET
More on Takeda Pharmaceutical
- EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze
- Takeda wins EU approval for Hyqvia CIDP indication
- Seeking Alpha’s Quant Rating on Takeda Pharmaceutical
- Historical earnings data for Takeda Pharmaceutical
- Dividend scorecard for Takeda Pharmaceutical